Basit öğe kaydını göster

dc.contributor.authorGiles, Y
dc.contributor.authorTezelman, S
dc.contributor.authorKapran, Y
dc.contributor.authorTerzioglu, T
dc.contributor.authorAksoy, M
dc.date.accessioned2021-03-04T13:10:47Z
dc.date.available2021-03-04T13:10:47Z
dc.date.issued2005
dc.identifier.citationAksoy M., Giles Y., Kapran Y., Terzioglu T., Tezelman S., "Expression of bcl-2 in papillary thyroid cancers and its prognostic value", ACTA CHIRURGICA BELGICA, cilt.105, sa.6, ss.644-648, 2005
dc.identifier.issn0001-5458
dc.identifier.otherav_7b03fac8-5283-4da1-986e-caff063979d3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/84242
dc.identifier.urihttps://doi.org/10.1080/00015458.2005.11679794
dc.description.abstractPurpose : Papillary thyroid cancer has a good prognosis. This favourable prognosis may be attributed to the apoptotic tendency of the cancer cells. This study aims to evaluate the expression of bcl-2, which is an antidote of apoptosis, and aims to evaluate the value of bcl-2 as a prognostic marker in papillary thyroid cancer.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectCerrahi Tıp Bilimleri
dc.titleExpression of bcl-2 in papillary thyroid cancers and its prognostic value
dc.typeMakale
dc.relation.journalACTA CHIRURGICA BELGICA
dc.contributor.department, ,
dc.identifier.volume105
dc.identifier.issue6
dc.identifier.startpage644
dc.identifier.endpage648
dc.contributor.firstauthorID176742


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster